The Value of Contrast-Enhanced Magnetic Resonance Imaging and Diffusion Weighted Imaging in Percutaneous Cryoablation for Renal Cell Carcinoma

徐淼,郭宏骞,汪维,连惠波,张士伟,张古田,李笑弓,甘卫东
DOI: https://doi.org/10.19460/j.cnki.0253-3685.2013.11.020
2013-01-01
Abstract:Objective To investigate the value of contrast-enhanced magnetic resonance imaging(MRI)and diffusion weighted imaging(DWI)in the diagnosis and follow-up of patients with renal cell carcinoma(RCC)treated with cryoablation.Methods The contrast-enhanced MRI and DWI were performed in 10patients with RCC.The size of the tumor and the ADC values under different b values of 400s/mm2 and 800s/mm2 were measured.The patients treated with cryoablation and followed up with MRI and DWI on the 1st week,in the 1st,3rd and 6th month after ablation.Results Before ablation,the tumor zones of 10cases were showed significant enhancement on T1-weighted MR image after gadolinium-enhanced.After ablation,10cases showed no enhancement on gadolinium-enhanced T1-weighted MR images.The renal cell carcinoma parenchyma presented high signal and necrosis part low signal on DWI in 10cases.When the b values were set at 400and 800s/mm2,respectively,there were significant differences between the ADC value in normal kidney and RCC(P0.05).Compared to before,the ADC values in the ablation zones under same b value were significantly higher on the 1st week and in the 1st month after ablation(P0.05).Conclusion Contrast-enhanced MRI is specifically valuable in finding residual tumor or the recrudesce of tumor in the patients with RCC treated with cryoablation.DWI and ADC value can be used in the diagnosis of RCC and the short-term follow-up of patients with RCC treated with cryoablation.
What problem does this paper attempt to address?